40 results Séminaire Compliance & Sustainability Le lundi 12 juin, Stibbe organise le séminaire Compliance & Sustainability. N'hésitez pas à vous inscrire. Seminarie Compliance & Sustainability Op maandag 12 juni organiseert Stibbe het seminarie Compliance & Sustainability. Aarzel niet om u in te schrijven. Het federale regeerakkoord door een publiekrechtelijke bril De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan. Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions. Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Stibbe assists a leading mining and metal manufacturer Stibbe assisted the president of the board of a leading mining and metal manufacturer in proceedings before the Financial Services and Markets Authority (FSMA) concerning a market manipulation case and a related criminal inquiry. Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe represents retail company Stibbe represented an upmarket department store company in the highly publicized proceedings before Belgium’s Supreme Court (Hof van Cassatie/Cour de cassation) regarding the validity of the national sales period legislation in light of EU law. Stibbe advises several banks in the aftermath of the Lernaut & Hauspie debacle Stibbe represented Artesia Bank Nederland in the Lernout & Hauspie case before the Court of Appeal in Ghent regarding the possible confiscation of shares worth EUR 30 million. We also assisted Dexia Bank in the L&H case before Belgium's Supreme Court. Stibbe represents Belgian Ministry of Finance Stibbe represented the Ministry of Finance in annulment proceedings pursued by the Flemish Bar Council before the Constitutional Court against the Belgian Preventative Money Laundering Act. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Stibbe represented several clients in an EU inquiry on alleged forgery and public procurement cases Stibbe assisted clients from a range of sectors in an inquiry conducted by the Anti-Fraud Office of the European Union concerning alleged forgery and public procurement cases within the EU. Pagination Current page 1 Page 2 Page 3 Next page
Séminaire Compliance & Sustainability Le lundi 12 juin, Stibbe organise le séminaire Compliance & Sustainability. N'hésitez pas à vous inscrire.
Seminarie Compliance & Sustainability Op maandag 12 juni organiseert Stibbe het seminarie Compliance & Sustainability. Aarzel niet om u in te schrijven.
Het federale regeerakkoord door een publiekrechtelijke bril De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan.
Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.
Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions.
Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review.
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Stibbe assists a leading mining and metal manufacturer Stibbe assisted the president of the board of a leading mining and metal manufacturer in proceedings before the Financial Services and Markets Authority (FSMA) concerning a market manipulation case and a related criminal inquiry.
Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.
Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe represents retail company Stibbe represented an upmarket department store company in the highly publicized proceedings before Belgium’s Supreme Court (Hof van Cassatie/Cour de cassation) regarding the validity of the national sales period legislation in light of EU law.
Stibbe advises several banks in the aftermath of the Lernaut & Hauspie debacle Stibbe represented Artesia Bank Nederland in the Lernout & Hauspie case before the Court of Appeal in Ghent regarding the possible confiscation of shares worth EUR 30 million. We also assisted Dexia Bank in the L&H case before Belgium's Supreme Court.
Stibbe represents Belgian Ministry of Finance Stibbe represented the Ministry of Finance in annulment proceedings pursued by the Flemish Bar Council before the Constitutional Court against the Belgian Preventative Money Laundering Act.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Stibbe represented several clients in an EU inquiry on alleged forgery and public procurement cases Stibbe assisted clients from a range of sectors in an inquiry conducted by the Anti-Fraud Office of the European Union concerning alleged forgery and public procurement cases within the EU.